McIlwraith John

Avg. Two Year Performance

(11%) Avg. Purchase Return
(5%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(4%)31%36%(15%)(11%)
Purchase Success Rate1 of 53 of 53 of 51 of 51 of 5
Average Sale Return----------
Sale Success Rate----------

Meridian Bioscience Inc.

Drugs » Diagnostic Substances

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--